Century Therapeutics (IPSC) SVP Carr Douglas Sells 1,658 Shares

What Happened

• Carr Douglas, SVP Finance & Operations of Century Therapeutics (IPSC), reported a sale of 1,658 shares on 2026-09-14. The shares were sold at $1.93 per share for gross proceeds of about $3,200. This was a sale (not a purchase) and per the filing was done to satisfy tax withholding obligations tied to vesting restricted stock units (RSUs).

Key Details

• Transaction date: 2026-09-14; Filing date: 2026-09-15.
• Transaction type/code: Sale (S); price: $1.93; shares sold: 1,658; proceeds ≈ $3,200.
• Footnote: The sale was automatic to cover tax withholding on vested RSUs and was not at the Reporting Person's discretion (footnote F1).
• Shares owned after the transaction: Not specified in the information provided.
• Timeliness: Filed one day after the transaction; no late filing flag reported.

Context

• Sales to cover tax withholding for vested RSUs are common and typically automated; they do not necessarily indicate a change in the insider’s view of the company. This transaction appears to be a routine tax-withholding sale rather than a discretionary sale for investment reasons.